Open | 13.38 |
Previous Close | 13.5 |
Day Range | 13.00 - 14.00 |
52-Week Range | 0.19 - 52.50 |
All-Time High | 485.00 |
Avg. Volume (50-day) | 408,813.03 |
EPS (TTM) | -0.02 |
Next Earnings Date | - |
Last Earnings Date | - |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | No |
P/E Ratio | -7.63 |
PEG Ratio | - |
Price to Book | 3.90 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | - |
Revenue per Share (TTM) | - |
Shares Outstanding | 133.488 M |
Share Float (%) | 126.70 M |
% Held by Institutions | 12.89 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 13.84 (-3.54%) |
+/- SMA(50) | 16.51 (-19.14%) |
+/- SMA(200) | 25.4 (-47.44%) |
5-Day Perf. | +7.23% |
1-Month Perf. | -23.8% |
3-Month Perf. | -45.29% |
6-Month Perf. | -50.21% |
YTD Perf. | -45.73% |
1-Year Perf. | +29.61% |
RSI(14) | 44.13 |
ATR(14) | 1.29 |
ADX(14) | 19.09 |
Beta (5Y) | -0.12 |
Sareum Holdings Plc engages in the discovery and development of drug candidates for the treatment of cancers and autoimmune diseases. Its drug discovery pipeline includes Chk1, TYK2, and Aurora+FLT3 kinases. The company was founded by Timothy John Mitchell, David Hugh Williams, and John Charles Reader on August 1, 2003 and is headquartered in Cambridge, the United Kingdom.
SAR.L has triggered the following predefined scans:
No Recent Scan Appearances |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.